Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/16730
Title: Review of the efficacy of green tea, isoflavones and aloe vera supplements based on randomised controlled trials
Authors: Williamson, Gary
Coppens, Patrick
Serra-Majem, Lluis 
Dew, Tristan
UNESCO Clasification: 3206 Ciencias de la nutrición
Keywords: Bone-Mineral Density
Antidiabetic Activity
Diabetes-Mellitus
Soy Isoflavones
Blood-Pressure, et al
Issue Date: 2011
Journal: Food and Function 
Abstract: We assess the evidence for health benefits of three commonly consumed plant food supplements (PFS), green tea, isoflavone and aloe vera, based on published systematic reviews of randomised controlled trials (RCTs). Whilst the potential benefits of green tea have been reported in a wide range of health areas, it is only in the area of the metabolic syndrome that the number of RCTs is approaching sufficient to judge such efficacy. Isoflavone supplements are widely used, and RCTs indicate that they affect bone resorption at lower doses in postmenopausal women undergoing estrogen-related bone loss, but this is only translated to attenuation of bone loss at higher doses of isoflavones. A systematic review on RCTs concluded that the effects of isoflavones on hot flashes in postmenopausal women were highly variable and no conclusions could be drawn. Despite the popularity of aloe vera as a PFS, the evaluation of its efficacy as a coadjuvant therapy for certain metabolic or digestive pathologies remains scarce; it constitutes a typical example of a naturally occurring ingredient whose efficacy in topical applications presupposes its efficacy in systemic applications. Nevertheless, its possible toxic effects on oral consumption call for caution in its utility as a PFS. Since 2007, efficacy evaluation of PFS in Europe has been covered by European Union Nutrition and Health Claims legislation. The European Food Safety Authority has adopted an approach relying on RCTs, while medicinal effects are accepted based on traditional use. In general, there are insufficient RCTs for claims to be made, and conclusive results on PFS should be obtained in the future by conducting studies with more homogeneous populations, by using supplements with optimised and measured bioavailability, and by conducting larger RCTs.
URI: http://hdl.handle.net/10553/16730
ISSN: 2042-6496
DOI: 10.1039/c1fo10101c
Source: Food & Function [ISSN 2042-6496], v. 2 (12), p. 753-9
Rights: by-nc-nd
Appears in Collections:Reseña
Thumbnail
Adobe PDF (257,63 kB)
Show full item record

SCOPUSTM   
Citations

16
checked on Sep 26, 2021

WEB OF SCIENCETM
Citations

14
checked on Nov 15, 2020

Page view(s)

35
checked on Sep 25, 2021

Download(s)

148
checked on Sep 25, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.